Relapsing Oligoarticular Septic Arthritis During Etanercept Treatment of Rheumatoid Arthritis
Authors:
- Adam MorAMAdam Mor
- Hal J. MitnickHMHal J. Mitnick
- Jeffry B. GreeneJGJeffry B. Greene
- Natalie AzarNANatalie Azar
- Reynaldo BudnahRBReynaldo Budnah
- Joseph FettoJFJoseph Fetto
- 1 April 2006
- journal article
- case report
- Published by Wolters Kluwer Health in JCR: Journal of Clinical Rheumatology
- Vol. 12 (2) , 87-89
Abstract
Septic arthritis is a commonly reported complication of rheumatoid arthritis (RA). Tumor necrosis factor alpha (TNF-alpha) plays an important role in host defense against infection. Inhibition of its activity could therefore be anticipated to augment the risk of infection. Both opportunistic and bacterial infections have been described in patients with RA treated with anti-TNF-alpha therapy. We describe a patient who experienced 2 episodes of septic arthritis. Both occurred while the patient was on etanercept. Recurrence developed despite prolonged parenteral antibiotic. To our knowledge, this is the first report of relapsing oligoarticular methicillin-sensitive Staphylococcus aureus septic arthritis despite prolonged antibiotic treatment in a patient receiving etanercept therapy. Our case underscores the advisability of discontinuing TNF-alpha blockade in patients with septic arthritis during prolonged antimicrobial therapy.Keywords
This publication has 7 references indexed in Scilit:
- Infections and anti–tumor necrosis factor α therapyArthritis & Rheumatism, 2003
- Infections and biological therapy in rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2003
- Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapyRheumatology, 2003
- MULTIFOCAL SEPTIC ARTHRITIS AND OSTEOMYELITIS CAUSED BY GROUP A STREPTOCOCCUS IN A PATIENT RECEIVING IMMUNOMODULATING THERAPY WITH ETANERCEPTThe Pediatric Infectious Disease Journal, 2003
- Infection complications associated with the use of biologic agentsRheumatic Disease Clinics of North America, 2003
- Experience with etanercept in an academic medical center: Are infection rates increased?Arthritis Care & Research, 2002
- Septic arthritis: a second decade of experienceAustralian and New Zealand Journal of Medicine, 1994